معرفی
Emil Ylikallio is an Associated Clinical Researcher at the Medical Neurogenetics Lab within the Stem Cells and Metabolism Research Program (STEMM) at the University of Helsinki. He concurrently serves as a Clinical Neurologist and heads the Rare Neurological Diseases Program at HUS Helsinki University Hospital. His academic appointments include positions in the Department of Neurosciences and Center of Excellence in Stem Cell Metabolism, where he supervises doctoral candidates in Clinical Research and Biomedicine.
Education includes:
- Licentiate of Medicine (Mechanisms and Effects of Mitochondrial DNA Instability) - University of Helsinki, Faculty of Medicine (2011)
- Master of Medical Sciences - University of Helsinki, Faculty of Medicine (2010)
Research focuses on molecular mechanisms of neurodegenerative conditions, with particular expertise in:
- Motor neuron disease pathogenesis and metabolic alterations
- Hereditary peripheral neuropathies including Charcot-Marie-Tooth variants
- Mitochondrial dysfunction in neurological disorders
- Stem cell models of neuromuscular diseases
Publication analysis reveals strong focus on:
- Genetic basis of peripheral neuropathies and motor neuron disorders
- Metabolic dysregulation in neuromuscular conditions
- Stem cell modeling of neurological diseases
- Identification of novel biomarkers and therapeutic targets
Current research leadership includes:
- Principal Investigator for 'Axon degeneration: new mechanisms, biomarkers and treatment' project (Funded by Academy of Finland)
- Project lead for Swedish Masonic Order-funded research (2025-2027)
Leads research activities through the Medical Neurogenetics Lab and collaborates extensively with HUS Neurocenter. Team focuses on translational research bridging molecular discoveries with clinical neurology applications.
